Table 1.
Author, Year | Recipient Feature | Number of Dogs | Frequency of FMT | Delivery Route | Clinical Effects | Effects on Fecal Microbiota | Method for Fecal Preparation |
---|---|---|---|---|---|---|---|
Burton et al., 2016 [57] | Weaning puppies, postweaning diarrhea | 11 FMT 12 controls |
5 days, once per day | Oral | No difference in fecal consistency between FMT and control puppies | Wide variability of microbiome in puppies, no clustering with donor microbiome observed | 10 mL fecal suspension (100 g pooled dam feces mixed with 200 mL 2% fat cow’s milk after filtration) |
Bottero et al., 2017 [55] | IBD refractory to conventional treatment | 16 adult dogs with severe, refractory IBD of >1 year duration | Oral treatment group received FMT q 48–72 h | 9 dogs endoscopy + oral, 7 dogs oral |
Overall, mean CCECAI seemed to decrease in most dogs following FMT. Heterogeneous clinical presentation and concurrent treatments complicate evaluation | Not applicable | 60–80 g feces for dogs <20 kg BW, 100–150 g for dogs > 20 kg BW. 1:1 dilution with 0.9% saline, filtered and mixed with low-fat yogurt as enrichment solution |
Pereia et al., 2018 [52] | Parvovirus infection | 33 received standard treatment, 33 received FMT in addition | FMT administered within 5–12 h of admission and q 48 h thereafter | Endoscopy | No difference in mortality rate, FMT dogs had quicker resolution of diarrhea, and shorter hospitalization | Not applicable | 10 g feces administered per puppy. 1:1 dilution with saline |
Nina et al., 2019 [53] | IBD refractory to antibiotic and immunosuppressive treatment over time | 10-year-old toy poodle | 9 treatments within 6 months | Endoscopy | Improved CIBDAI. | Increased in Fusobacteria, Firmicutes and Bacteroidetes, decreased in Proteobacteria. Clustered phylogenetically with donor | Feces diluted 1:3 with ringer lactate. The dog received approximately 3 g feces/kg body weight |
Sugita et al., 2019 [37] | Intermittent large bowel diarrhea, 4 months of duration, feces positive for CD (PCR and toxins A & B) | 8-month-old French bulldog | Oral | Normalization of fecal consistency and defecation frequency within 2–3 days, without recurrence of CD or diarrhea over 190 days | Not applicable | 30 mL fecal suspension (60 g feces diluted in 50 mL tap water after filtration) given orally. Equivalent to approximately 2.5–3 g feces/kg BW | |
Chitman et al., 2020 [49] | Uncomplicated acute diarrhea of <14 days duration | 11 dogs received a single FMT, 7 dogs received metronidazole 15 mg/kg q 12 h for 7 days | Endoscopy | Lower (better) fecal score at days 7 and 28 for both treatments, FMT fecal score lower than metronidazole at day 28 | Fecal dysbiosis indexes better with FMT than metronidazole at days 7 and 28. FMT dogs tended to cluster healthy dogs at day 28, unlike metronidazole dogs | Fresh feces mixed with 60 mL 0.9% NaCl in a blender. Blend on high until the stool is liquefied and no larger pieces are seen. For very large dogs a larger volume of saline may be needed to obtain sufficiently liquefied fecal solution | |
Diniz et al., 2021 [56] | Chronic-recurring pasty large bowel diarrhea | 4-year-old female golden retriever | Received FMT via colonoscopy | Colonoscopy | Clostridium difficile no longer present in the dog’s stool | Not applicable | Approximately 65 g of feces were diluted in 250 mL of sterilized PBS |
Gal et al., 2021 [51] | Canine acute hemorrhagic diarrhea syndrome | 8 dogs aged 3–12 years old | Received FMT via colonoscopy | Colonoscopy | There were no significant differences in median AHDS clinical scores between FMT-recipients and sham-treated controls | Increased microbiota diversity. Short-chain fatty acid producers including Eubacterium biforme, Faecalibacterium prausnitzii, and Prevotella copri were significantly decreased | Stool was homogenized at room temperature in a sterilized blender at a ratio of 1-part stool/4 parts saline. The suspension was passed through a sterilized sieve to remove large particles |